Health Care Industry

Industry: Email Alert RSS Feed
Comments

United Research Laboratories/Mutual Pharmaceutical Co

Drug Store News, Sept 27, 2004

United Research Laboratories/Mutual Pharmaceutical Co. stated that a court briefing should conclude in October, with oral arguments set for early 2005 for its quinapril HC1 tablets, the generic version of Pfizer's $589 million drug Accupril. It also is actively defending its gabapentin capsules, the generic version of Pfizer's $1.6 billion drug Neurontin.

Most RecentHealth Care Articles

In other news, the company expects to launch its metaxalone 400 mg tablets, the generic version of King Pharmaceutical's $188 million drug Skelaxin; and its felodipine HCl ER tablets, the generic version of AstraZeneca's $246 million drug Plendil ER, both within the next three months to six months.

COPYRIGHT 2004 Reproduced with permission of the copyright holder. Further reproduction or distribution is prohibited without permission.
COPYRIGHT 2008 Gale, Cengage Learning
 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:
  1. You are currently: a Guest |
  4.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement

Content provided in partnership with Thompson Gale